Itsuwa Interim Report: Operating Revenue Decreases by 24% to 120M Yuan, Contract Manufacturing Business Sees 29.55% Drop

Business by 2FIRSTS.ai
Aug.26.2024
Itsuwa Interim Report: Operating Revenue Decreases by 24% to 120M Yuan, Contract Manufacturing Business Sees 29.55% Drop
Itsuwa Co., Ltd. (833767) recently released its 2024 half-year report, revealing a 24% drop in revenue compared to last year.

Recently, Shenzhen Itsuwa Co., Ltd. (833767) released its 2024 interim report.

 

The report shows that in the first half of 2024, the total operating revenue was approximately 120 million yuan, a decrease of 24% compared to the same period last year. The gross profit margin was 27.46%, a decrease of 7.73% from the previous year. 

 

The net loss attributable to shareholders of the listed company was approximately 19.35 million yuan, a decrease of 184.42% compared to the same period last year.

 

Itsuwa Interim Report: Operating Revenue Decreases by 24% to 120M Yuan, Contract Manufacturing Business Sees 29.55% Drop
Itsuwa's 2024 semi-annual report

 

Itsuwa Interim Report: Operating Revenue Decreases by 24% to 120M Yuan, Contract Manufacturing Business Sees 29.55% Drop
Revenue situation of own brands and OEM/ODM

 

The report stated that the company continued to focus on overseas markets such as Europe and America in the first half of the year. By the first half of 2024, there was fierce competition among e-cigarette products, with the company's differentiated advantage not being clear, resulting in a decrease in sales.

Itsuwa Interim Report: Operating Revenue Decreases by 24% to 120M Yuan, Contract Manufacturing Business Sees 29.55% Drop

 

Among them, the revenue from self-owned brands was approximately 39.22 million yuan, a decrease of 9.02% compared to the same period last year, with a gross profit margin of 25.91%, down by 3.48% from the previous year; revenue from OEM/ODM was approximately 82 million yuan, a significant decrease of 29.55% compared to the same period last year, with a gross profit margin of 28.21%, down by 9.13% from the previous year.

 

Itsuwa Interim Report: Operating Revenue Decreases by 24% to 120M Yuan, Contract Manufacturing Business Sees 29.55% Drop
Domestic sales income and export sales income situation

 

Furthermore, due to a decrease in outsourcing orders, the company reported a 76.50% decrease in domestic sales revenue compared to the same period last year, as well as a 2.58% decrease in domestic gross profit margin. This is primarily because of intense competition in the overseas e-cigarette market for homogenized products, leading to a decrease in prices for sales to companies holding e-cigarette tobacco business licenses (brand-holding enterprises) compared to the same period last year.

 

Due to intense competition in the overseas market for homogenized products in the first half of the year, export revenue decreased by 23.39% compared to the same period last year, while export costs decreased by 13.92% compared to the same period last year.

 

The company stated that their research and development focus in the first half of 2024 will be on pod e-cigarettes and cartridge e-cigarettes, as well as promoting their own brands VAPESOUL and VOOM in the high-end e-cigarette market.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
The U.S. FDA has set December 8, 2025, 11:59 p.m. ET as the closing date for public comments on the MRTP renewal applications submitted by Philip Morris Products S.A. for several IQOS heated tobacco products.
Nov.07 by 2FIRSTS.ai
British Museum Ends Long-Running Sponsorship with Japan Tobacco International
British Museum Ends Long-Running Sponsorship with Japan Tobacco International
According to The Guardian, the British Museum has ended its 15-year sponsorship with Japan Tobacco International after government inquiries into whether the deal breached WHO tobacco-control rules. Critics had long opposed the partnership, while the museum said sponsorship remains essential for its financial stability and public access.
Nov.20
PMI Launches New ZYN Nicotine Pouch in the Philippines, Available Simultaneously at IQOS Stores and on the Official Website
PMI Launches New ZYN Nicotine Pouch in the Philippines, Available Simultaneously at IQOS Stores and on the Official Website
PMI’s Philippine affiliate, PMFTC, has launched the new ZYN Bright Green 1.5 mg nicotine pouch in Manila with refreshed packaging, calling it the latest step in the company’s “smoke-free” transition initiated in 2016. The product will be available starting in November at IQOS stores across Metro Manila and on the official website.
Nov.10 by 2FIRSTS.ai
Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point
Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point
As regulations tighten, consumer habits evolve, and new nicotine products reshape the market, the cigar industry is undergoing a quiet but profound transformation. In this exclusive interview, 2Firsts speaks with Cigar Sense — a data-driven sensory analysis firm — to explore what’s really changing in cigars, and what it means for manufacturers, retailers, and smokers around the world.
Nov.10
Bloomberg-Backed Campaign Wins as Denver Votes to Ban Flavored Nicotine
Bloomberg-Backed Campaign Wins as Denver Votes to Ban Flavored Nicotine
Denver voters have upheld the city’s ban on flavored nicotine products—including fruity vapes and menthol cigarettes—with 72% in favor during the Nov. 4 election. The “Yes on 310” campaign, backed by $5 million from Michael Bloomberg, celebrated the result as a major victory for youth health. Opponents, mostly local vape shop owners, warned of economic harm and called the spending imbalance unfair.
Nov.05 by 2FIRSTS.ai
Imperial Brands Urges Retailers to Engage in Government Consultation on Tobacco and Vapes Bill
Imperial Brands Urges Retailers to Engage in Government Consultation on Tobacco and Vapes Bill
Imperial Brands is calling on UK retailers to take part in the Government’s consultation on the Tobacco and Vapes Bill, which will shape a new licensing framework for nicotine product sales across England, Wales and Northern Ireland. The Department of Health and Social Care’s call for evidence closes on 3 December 2025. Imperial Brands stresses this is a key chance for retailers to influence policy, support fair competition, and help curb illicit sales.
Nov.04